Cosenza, Italy

Vincenzo Santagada

USPTO Granted Patents = 8 



Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 70(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Vincenzo Santagada: Innovator in Non-Steroidal Anti-Inflammatory Drugs

Introduction

Vincenzo Santagada is a notable inventor based in Cosenza, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory drugs (NSAIDs). With a total of 8 patents, his work focuses on enhancing the efficacy and safety of these medications.

Latest Patents

One of his latest patents involves hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs. This invention relates to derivatives of NSAIDs that possess improved anti-inflammatory properties, making them useful in treating inflammation, pain, and fever. The novel compounds are designed to release hydrogen sulfide (HS), which helps in reducing side effects associated with traditional NSAIDs. Another significant patent includes 4-hydroxythiobenzamide derivatives of drugs. These derivatives incorporate the H2S-releasing moiety, which can be covalently linked to the drug or form a salt with it. The compounds exhibit enhanced activity and reduced side effects, showcasing Santagada's innovative approach to drug development.

Career Highlights

Throughout his career, Vincenzo Santagada has worked with various companies, including Antibe Therapeutics Inc. and Antibe Holdings Inc. His expertise in drug formulation and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Santagada has collaborated with notable professionals in his field, including John L. Wallace and Giuseppe Cirino. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Vincenzo Santagada's contributions to the field of pharmaceuticals, particularly in the area of non-steroidal anti-inflammatory drugs, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to enhancing drug efficacy while minimizing side effects, making a significant impact in the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…